Biotinylated Nipah virus Post-Fusion glycoprotein, His,Avitag(TM) (MALS verified), Human

Catalog Number: ABS-PON-V82E3-200UG
Article Name: Biotinylated Nipah virus Post-Fusion glycoprotein, His,Avitag(TM) (MALS verified), Human
Biozol Catalog Number: ABS-PON-V82E3-200UG
Supplier Catalog Number: PON-V82E3-200ug
Alternative Catalog Number: ABS-PON-V82E3-200UG
Manufacturer: AcroBiosystems
Host: Human
Category: Proteine/Peptide
Species Reactivity: Virus
Conjugation: Biotin
Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses discovered in the midto late 1990s that possess a broad host tropism and are known to cause severe and often fatal disease in both humans and animals. HeV and NiV infect host cells through the coordinated efforts of two envelope glycoproteins. The G glycoprotein attaches to cell receptors, triggering the fusion (F) glycoprotein to execute membrane fusion. G is a type II homotetrameric transmembrane protein responsible for binding to ephrinB2 or ephrinB3 (ephrinB2/B3) receptors. F is a homotrimeric type I transmembrane protein that is synthesized as a premature F0 precursor and cleaved by cathepsin L during endocytic recycling to yield the mature, disulfidelinked, F1 and F2 subunits. Upon binding to ephrinB2/B3, NiV G undergoes conformational changes leading to F triggering and insertion of the F hydrophobic fusion peptide into the target membrane. Subsequent refolding into the more stable postfusion F conformation drives merger of the viral and host membranes to form a pore for genome delivery to the cell cytoplasm. - Proteine/Peptide
Molecular Weight: 56.2 kDa
Tag: C-10*His & C-Avi
NCBI: 9
Buffer: 0.1 M Sodium citrate, pH5.5
Expression System: Ile 27 - Asn 99 & Gly 117 - Ser 488
Purity: 90%
Form: Powder
Target: Postfusion glycoprotein F0/post-F protein (NiV)
PON-V82E3-200ug